Physician profile
Renee Moss
NPI 1265865802
$1,235.90
in general payments reported to CMS, 2019-2025
20 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $344 · 2022: $152 · 2023: $333 · 2024: $176 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $325.00 | 2021 | |
| Shield Therapeutics INC | $145.59 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $98.41 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $88.33 | 2023-2024 | Myfembree |
| Daiichi Sankyo INC. | $59.57 | 2022-2023 | Injectafer |
| Myovant Sciences INC. | $57.90 | 2022 | |
| Exeltis, USA INC. | $56.06 | 2022-2025 | Slynd |
| Pfizer INC. | $53.18 | 2023-2024 | |
| Organon LLC | $50.88 | 2024-2025 | Jada System |
| Biogen, INC. | $44.59 | 2025 | Zurzuvae |
| Millicent US INC | $39.29 | 2025 | Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $38.65 | 2024-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Baxter Healthcare | $30.70 | 2024 | Perclot |
| Vertex Pharmaceuticals Incorporated | $28.95 | 2025 | |
| Abbvie INC. | $25.11 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $20.29 | 2022 | |
| Coopersurgical, INC. | $19.08 | 2021 | |
| Convatec INC. | $18.63 | 2023 | |
| Minerva Surgical, INC | $18.36 | 2025 | |
| Meditrina | $17.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.